| Trial Name: |
A Long-term Study of Ambrisentan in Patients with Pulmonary Hypertention
|
| Intro: |
ARIES-3: A Phase 3, Long-term, Open-label, Multicenter Safety and Efficacy Study of Ambrisentan in Subjects with Pulmonary Hypertension |
| Condition: |
|
| Description: |
ARIES-3: A Phase 3, Long-term, Open-label, Multicenter Safety and Efficacy Study of Ambrisentan in Subjects with Pulmonary Hypertension Start Date: 6/2008 End: When enrollment is full. |
| Criteria: |
|
| Contact: |
Please contact David Haney at (216) 844-2381. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back